BLFS Q3 2022 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q3 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$41M+20.6% YoY

Gross Profit

$14M33.7% margin

Operating Income

-$9M-22.2% margin

Net Income

-$10M-24.4% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+0.5%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$950,000

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$488M

Total Liabilities

$79M

Stockholders' Equity

$408M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$34M	+20.6%
Gross Profit	$14M	$9M	+53.7%
Operating Income	-$9M	-$11M	+18.8%
Net Income	-$10M	$79,000	-12703.8%

Revenue Segments

Rental Revenue

$6M96%

Service Revenue

$270,0004%